-
1
Phosphorylated tau217 can predict Alzheimer's onset.
-
2
Study published in Nature Medicine.
-
3
Developed statistical models from p-tau217 blood levels.
-
4
Plasma-based model enhances accessibility over PET scans.
-
5
P-tau217 increases during preclinical phase.
-
6
Models show feasibility and accuracy across populations.
-
7
Aim to inform patients on symptom onset timing.
Original Source(s)
Blood Test Forecasts Alzheimer's Onset
Plasma p-tau217 “clocks” estimate timing of symptoms years before clinical diagnosis
March 9, 2026
-
2 min
Related Content
Retinal Clues to Alzheimer’s Pathology
Study detected Chlamydia pneumoniae and inflammasome-related proteins in retinal specimens
March 5, 2026
-
2 min
Cenobamate Shows Stronger Real-World Seizure Control
Large retrospective analysis highlights differences in seizure control, retention, and adverse effects among newer agents
by Henry Thomas
March 4, 2026
-
2 min
GLP-1 RAs in Chronic Migraine
Investigators evaluate health care utilization and treatment patterns vs topiramate in an active-comparator study.
March 3, 2026
-
3 min